On this episode of Stock Movers:
- Novo Nordisk (NOVOB) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly (LLY). The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker’s ability to compete in the obesity market it pioneered.
- Copper hit a fresh all-time high above $12,000 a ton due to severe mine outages and trade dislocations linked to US President Donald Trump’s tariff agenda. Shares of Albemarle climbed as a result.
- The US Navy announced plans to build a new class of warship, the FF(X), as part of President Donald Trump's "Golden Fleet" bid to revive US shipbuilding. That caused shares of Huntington Ingalls Industries Inc. to rise.

See omnystudio.com/listener for privacy information.